Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
AMD Forecast: New Algorithm Offers 94% Accuracy
Researchers at Duke University have developed a computer program that can predict with 94% accuracy whether an individual’s age-related macular degeneration (AMD) will deteriorate within a year. The deep learning algorithm, featured in an article within JAMA Ophthalmology, evaluates comprehensive…
Ocular Therapeutix Gets FDA Agreement for Wet AMD Trial
Ocular Therapeutix has obtained written FDA approval for the comprehensive design of its pivotal phase 3 clinical trial, known as the SOL trial, which evaluates Axpaxli (axitinib intravitreal implant) for treating wet age-related macular degeneration (AMD) under a Special Protocol…
What Is Idiopathic Multifocal Choroiditis and How to Manage It|OBN
What Is Idiopathic Multifocal Choroiditis? Idiopathic Multifocal Choroiditis (IMFC) is a rare eye condition that primarily affects the choroid, a vascular layer situated between the retina and the sclera (the white part of the eye). The condition is characterized by…
Bausch + Lomb Acquires Eye Drugs from Novartis
Bausch + Lomb has announced that it will acquire the dry eye drug Xiidra (lifitegrast ophthalmic solution) 5% from Novartis. Xiidra is an eye drop without steroids that has received specific approval for treating the signs and symptoms of dry…
What Is Leber Congenital Amaurosis?
Leber Congenital Amaurosis (LCA) is a rare genetic disorder that affects the retina, the part of the eye responsible for sensing light and sending visual signals to the brain. It is a severe form of retinal dystrophy, which means that…
Dysphotopsia: Causes, Symptoms, Treatment | OBN
What Is Dysphotopsia? Dysphotopsia, a term often sending shivers down the spine of even the most experienced ophthalmologists, refers to a spectrum of visual disturbances that patients may experience following cataract surgery. It is derived from the Greek words ‘dys’…
Japan’s PMDA Approves Aurion Biotech’s NDA
Aurion Biotech announced that it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its pioneering cell therapy, VyznovaTM, designed for treating bullous keratopathy of the cornea. According to the company, this represents the world’s first…
Tiny Eye Implant: A Diabetes Treatment Option
In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…
Parinaud Oculoglandular Syndrome: Causes and Treatment
Parinaud oculoglandular syndrome is a relatively rare yet intriguing medical condition that intertwines ocular and glandular manifestations. Characterized by its distinct combination of eye-related symptoms and glandular involvement, this syndrome presents a unique challenge for both patients and medical professionals.…
Herpes Zoster Ophthalmicus | OBN
Herpes Zoster Ophthalmicus (HZO), commonly known as shingles, is a viral disease characterized by a unilateral painful skin rash in one or more dermatome distributions of the fifth cranial nerve (trigeminal nerve), shared by the eye and ocular adnexa. Herpes…